期刊文献+

小剂量奈达铂同步放疗对中晚期宫颈癌作用 被引量:1

Effect of Low-dose Nedaplatin Combined with Radiotherapy on Advanced Cervical Cancer
下载PDF
导出
摘要 目的对小剂量奈达铂与顺铂周疗方案同步放疗治疗中晚期宫颈癌的临床疗效及毒副反应进行分析。方法收集2012年7月至2015年12月中晚期宫颈癌患者(均为鳞状细胞癌)86例随机分两组。顺铂组采用顺铂周疗方案同步放疗治疗,奈达铂组采用小剂量奈达铂周疗方案同步放疗治疗。比较两组患者中晚期宫颈癌治疗总有效率,毒副作用发生率,治疗前和治疗后患者生存质量评分以及KPS评分的差异。结果奈达铂组患者中晚期宫颈癌治疗总有效率和顺铂组无显著差异,P>0.05;奈达铂组肾脏毒性、恶心呕吐等毒副作用发生率低于顺铂组,而血液毒性反应明显高于顺铂组,P<0.05。治疗前两组生存质量评分以及KPS评分比较无显著差异,P>0.05;治疗后奈达铂组生存质量评分以及KPS评分改善幅度更大,P<0.05。结论小剂量奈达铂周疗方案同步放疗治疗中晚期宫颈癌的临床疗效确切,优于顺铂周疗方案同步放疗治疗,可有效改善病情,减少肾脏毒性、恶心呕吐等毒副作用的发生,但也增加了血液毒性,需引起注意。 Objective To analyze the clinical efficacy and toxicity of low dose neodymium and cisplatin in the treatment of advanced cervical cancer. Methods A total of 86 patients were enrolled in this study from July 2012 to December 2015 in patients with cervical cancer ( both squamous cell carcinoma). Cisplatin group with cisplatin peripheral therapy concurrent radiotherapy treatment, neda platinum group using a small dose of neda platinum treatment of concurrent radiotherapy treatment. The total effective rate of treatment of advanced cervical cancer was compared between the two groups, the incidence of side effects, the difference between the quality of life and the KPS score before and after treatment. Results The total effective rate of treatment of advanced cervical cancer in patients with nedaplatin was not significantly different from that in cisplatin group ( P 〉 0. 05 ). The incidence of side effects such as renal toxicity and nausea and vomiting in nedaplatin group was lower than that in cisplatin group The response was significantly higher than that of cisplatin group ( P 〈 0. 05 ) . There was no significant difference between the two groups before and after treatment ( P 〉 0. 05 ). The quality of life score and KPS score of nedaplatin group were significantly higher than those of the control group ( P 〈 0. 05 ) . Conclusion The therapeutic effect of low dose neodymium radiotherapy combined with radiotherapy in the treatment of advanced cervical cancer is better than that of cisplatin therapy. It can effectively improve the condition, reduce the toxicity of kidney, nausea and vomiting and other side effects, But also increased blood toxicity, need attention.
出处 《广东微量元素科学》 CAS 2017年第7期57-60,共4页 Trace Elements Science
关键词 小剂量奈达铂 顺铂周疗方案 同步放疗 中晚期宫颈癌 临床疗效 low - dose nedaplatin cisplatin weekly regimen concurrent radiotherapy advanced cervical cancer clinical efficacy
  • 相关文献

参考文献8

二级参考文献56

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2张频,冯奉仪,吴令英,胡毅,刘基崴,高亚杰,关晓倩,南克俊,索爱莉,王秀问,张茂宏,张文东,李朝午,张阳,赵金波.奈达铂治疗恶性肿瘤的临床研究[J].中华肿瘤杂志,2006,28(3):230-234. 被引量:60
  • 3徐瑞华,史艳侠,管忠震,姜文奇,黄河,马智勇,王建华,胡晓桦,谢伟敏,李星庚,刘亚利,潘良熹,戴爱娣,庄武,张春.国产奈达铂治疗食管癌的Ⅱ期临床试验报告[J].癌症,2006,25(12):1565-1568. 被引量:44
  • 4陈丽昆,徐光川,管忠震,梁颖,杨群英.奈达铂或顺铂联合紫杉醇治疗晚期非小细胞肺癌的随机对照研究[J].中华肿瘤杂志,2007,29(6):437-440. 被引量:36
  • 5孙燕.临床肿瘤内科手册.4版.北京:人民卫生出版社,2003.571.
  • 6Ostrowski MJ.An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavity bleomycin.Cancer,1986,5:721-727.
  • 7Postmus PE,Brambilla E,Chansky K,el al.The IASLC lung cancer staging project:proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer.J Thorac Oncol,2007,2:686-693.
  • 8周济昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2003.576-577.
  • 9Taguchi T, Wakui A, Nabeya K, et al. A phase Ⅱ clinical study of cisdiammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group [J]. Gan To Kagaku Ryoho, 1992, 19 (4): 483-488.
  • 10Nishida M, Satoh Y, Nishide K, et al. Phase I study of a combination chemotherapy of nedaplatin and cisplatin[J]. Gan To Kagaku Ryoho, 1999, 26 (14): 2209-2215.

共引文献169

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部